UnitedHealth Group's Q4 and full-year 2017 earnings call revealed strong financial performance, with revenues exceeding $201 billion and adjusted earnings per share growing 25% to $10.07. The company expects to benefit from tax reform, with estimated improved earnings and cash flows of $1.7 billion in 2018. Management expressed optimism about the company's growth prospects, driven by its diversified businesses, including Optum and UnitedHealthcare. 

The company's guidance for 2018 has been revised to reflect the lower expected tax rate, with adjusted net earnings per share expected to be in the range of $12.30 to $12.60. The medical care ratio is expected to be in the range of 81.5% plus or minus 50 basis points. UnitedHealth Group's strong financial position and diversified business portfolio are expected to drive long-term growth and stability.

Given the strong financial performance and positive guidance, I predict a positive impact on the stock price over the next 1-2 weeks.

[1]